Skip to content
411 PRESS
WarningRecall #D-0718-2026Drug / Pharmaceutical

Rohto-Mentholatum (Vietnam) Co. Recalls Rohto Cooling Eye Drops Optic Glow

Rohto-Mentholatum (Vietnam) Co., Ltd. · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycol 0.2%), Sterile, 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742010916, NDC 10742-8160-1

Reason for Recall

Lack of Assurance of Sterility

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

Nationwide within the United States

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

A Class II FDA recall has been issued for a pharmaceutical product from Rohto-Mentholatum (Vietnam) Co., Ltd., initiated on July 14, 2026. Lack of Assurance of Sterility. This recall covers 1,278,457 cartons, distributed nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.

Independent news on labor, safety, and accountability.